
Adult Immunization
Latest News

Nearly 18 Million Middle-Aged US Women Overdue for Cancer Screening, Study Finds
The Risk of Waiting: The Case for Lower LDL-C – Earlier in the Atherosclerotic Disease Continuum

Social Determinants May Improve Disease Risk Prediction Beyond Genetics Alone

FDA Issues CRL to Cytisinicline for Smoking Cessation

Home Sleep Testing for GLP-1 Coverage Shows Modest Diagnostic Yield in New Study

Shorts










Latest Videos
All News

SLEEP 2026: In an 8-week randomized trial, reishi mushroom extract reduced Insomnia Severity Index scores more than melatonin in adults with chronic insomnia.

Prenatal sleep expectations predicted postpartum sleep quality above parity and psychiatric history, with postpartum anxiety further worsening outcomes.

High-risk rural patients were less likely than urban patients to be referred for obstructive sleep apnea evaluation in primary care.

New research suggests EDS combined with prolonged sleep-onset latency is linked to 3x greater risk of incident hypertension and 2x greater risk of prevalent hypertension.

The EEG-guided MeRT system is the first personalized, biomarker-guided neuromodulation technology to receive FDA clearance for PTSD.

AD109 Reduces OSA Severity in Phase 3 Trial of CPAP-Intolerant Adults
AD109 reduced apnea-hypopnea index versus placebo in a phase 3 trial of adults with OSA unable or unwilling to use CPAP.

Takeda reported phase 3 data showing zasocitinib achieved higher week 16 PASI 100 responses than deucravacitinib in plaque psoriasis.

Late-breaking SLEEP 2026 findings bring primary-care-ready insights on insomnia drugs, sleep apnea genetics, menopausal sleep, and GLP-1 links.

SLEEP 2026: Women with moderate-to-severe obstructive sleep apnea reported worse sleep, fatigue, anxiety, headaches, and nocturia than men.
































































































































































































































